Log in to save to my catalogue

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosin...

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_84e3555558d84502948c3d20dd3741d5

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing

About this item

Full title

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-07, Vol.13 (1), p.12107-12107, Article 12107

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In medical trials, ‘blinding’ ensures the equal distribution of expectancy effects between treatment arms in theory; however, blinding often fails in practice. We use computational modelling to show how weak blinding, combined with positive treatment expectancy, can lead to an uneven distribution of expectancy effects. We call this ‘activated expec...

Alternative Titles

Full title

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_84e3555558d84502948c3d20dd3741d5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_84e3555558d84502948c3d20dd3741d5

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-34938-7

How to access this item